Keyphrases
Tumor
100%
Adaptive Immunity
100%
Effector Cells
100%
Plasmacytoid DC
100%
Tumor Killing
100%
Imiquimod
100%
Toll-like Receptor 7 (TLR7)
50%
IFNAR1
40%
IFN Receptors
10%
Mouse Model
10%
Mast Cells
10%
Immune Response
10%
Adaptive Immune Response
10%
Tumor Cells
10%
CD8+
10%
Antitumor Properties
10%
Receptor 1
10%
Skin Tumor
10%
Antitumor Effect
10%
Immune Cells
10%
Tumor Regression
10%
Granzyme B
10%
Melanoma
10%
Skin Inflammation
10%
Chemokine (C-C motif) Ligand 2 (CCL2)
10%
Myeloid Differentiation Factor 88 (MyD88)
10%
Tumor-bearing Mice
10%
Direct Contribution
10%
CD8+ Cells
10%
Synthetic Compounds
10%
Cytolytic Proteins
10%
Chemokine CCL2
10%
Cream Formulation
10%
Topical Imiquimod
10%
Immunology and Microbiology
Adaptive Immune System
100%
Effector Cell
100%
Imiquimod
100%
TLR7
62%
Secretion (Process)
12%
CD8
12%
Mast Cell
12%
Mouse Model
12%
Immunocompetent Cell
12%
Tumor Cell
12%
Immune Response
12%
Monocyte Chemotactic Protein 1
12%
Upregulation
12%
TNF related apoptosis inducing ligand
12%
Granzyme B
12%
Dermatitis
12%
CCL2
12%
CD8+ Cell
12%